Sonoma Biotherapeutics, Inc.
Biotechnology company · South San Francisco, California, United States
Sonoma Biotherapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $265 million sold in a notice filed in 2021.
Sonoma Biotherapeutics at a glance
What does Sonoma Biotherapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $265 million sold (2021).
Frequently asked questions about Sonoma Biotherapeutics
Where is Sonoma Biotherapeutics headquartered?
Sonoma Biotherapeutics, Inc. is headquartered in South San Francisco, California, United States.
What does Sonoma Biotherapeutics do?
Sonoma Biotherapeutics, Inc. is a biotechnology company.
When was Sonoma Biotherapeutics founded?
The earliest incorporation on record for Sonoma Biotherapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences